Marcia Brose, MD, PhD

Marcia Brose, MD, PhD

Episodes

Specialty:

All

Year:

All

EP. 1: Approval of Lenvatinib: More Options

March 4th 2015

EP. 2: Who Are the Best Candidates for TKIs?

March 4th 2015

EP. 3: Interpreting Whole Body Scans

March 4th 2015

EP. 4: Genetic Testing: What Role Do Mutations Play?

March 4th 2015

EP. 5: Treatments After Progression in DTC

March 4th 2015

EP. 6: When to Refer a Patient to a Medical Oncologist

March 4th 2015

EP. 7: Monitoring During Active Surveillance and Treatment

March 4th 2015

EP. 8: Key Findings From DECISION and SELECT Trials

March 4th 2015

EP. 9: Current and Future Targets in Thyroid Cancer

March 4th 2015

EP. 10: More Personalized Therapy Needed to Improve Survival

March 4th 2015

EP. 11: Medullary Thyroid Cancer: What is Available?

March 4th 2015

Trending on OncLive

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

Mo-Rez Advances Into Combination Studies Following Robust Responses in Gynecologic Cancers

mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC

Harold P. Freeman, MD, Pioneer of Patient Navigation and Cancer Disparities Research, Dies at 93